UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-07, Vol.16 (7), p.1437-1441

2018

Volltextzugriff (PDF)

Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register

Journal of thrombosis and haemostasis, 2015-11, Vol.13 (11), p.1999-2003

2015

Volltextzugriff (PDF)

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA

Hematology, Transfusion and Cell Therapy, 2020-11, Vol.42, p.74-75

2020

Volltextzugriff (PDF)

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant

The New England journal of medicine, 2017-12, Vol.377 (23), p.2215-2227

2017

Volltextzugriff (PDF)

The use of thromboelastography for the peripartum management of a patient with platelet storage pool disorder

International journal of obstetric anesthesia, 2011-04, Vol.20 (2), p.173-177

2011

Volltextzugriff (PDF)

Pulmonary embolism in sickle cell disease: a case–control study

Journal of thrombosis and haemostasis, 2012-05, Vol.10 (5), p.760-766

2012

Volltextzugriff (PDF)

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

Journal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1788-1800

2014

Volltextzugriff (PDF)

Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study

Journal of thrombosis and haemostasis, 2015-11, Vol.13 (11), p.1980-1988

2015

Volltextzugriff (PDF)

Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C

American journal of transplantation, 2006-12, Vol.6 (12), p.2983-2993

2006

Volltextzugriff (PDF)

Coronary atherosclerosis and cardiovascular mortality in hemophilia

Journal of thrombosis and haemostasis, 2010-01, Vol.8 (1), p.208-211

2010

Volltextzugriff (PDF)

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development

Blood advances, 2020-11, Vol.4 (22), p.5785-5796

2020

Volltextzugriff (PDF)

Inhibitor Recurrence Following Immune Tolerance Induction: A Multicenter Retrospective Cohort Study

Journal of thrombosis and haemostasis, 2015-10, Vol.13 (11), p.1980-1988

2015

Volltextzugriff (PDF)

Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study

American journal of transplantation, 2016-02, Vol.16 (2), p.679-687

2016

Volltextzugriff (PDF)

Lack of desmopressin (DDAVP) response in men with hemophilia A following liver transplantation

Journal of thrombosis and haemostasis, 2005-10, Vol.3 (10), p.2259-2263

2005

Volltextzugriff (PDF)

Screening for von Willebrand disease in children: a case–control study

Journal of thrombosis and haemostasis, 2011-05, Vol.9 (5), p.1086-1089

2011

Volltextzugriff (PDF)

On the cutting edge: von Willebrand factor propeptide and thrombosis

Journal of thrombosis and haemostasis, 2006-12, Vol.4 (12), p.2553-2555

RAGNI, M. V.

2006

Volltextzugriff (PDF)

RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD

Journal of thrombosis and haemostasis, 2007-07, Vol.5, p.O-T-062-O-T-062

2007

Volltextzugriff (PDF)

The Prevalence of Reduced VWF Survival Phenotype (Type 1C VWD) in Type 1 Index Cases Recruited into the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB - VWD)

Blood, 2007-11, Vol.110 (11), p.2133-2133

2007

Volltextzugriff (PDF)

Novel VWF Sequence Variations Identified in Normal Controls and Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD)

Blood, 2007-11, Vol.110 (11), p.709-709

2007

Volltextzugriff (PDF)

Common VWF Haplotypes in Normal African-Americans and Caucasians Recruited into the ZPMCB-VWD and Their Impact on VWF Laboratory Testing

Blood, 2007-11, Vol.110 (11), p.714-714

2007

Volltextzugriff (PDF)

New-generation recombinant factor concentrates: bridge to gene therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2001-01, Vol.7 (s1), p.28-35

Ragni, M.V.

2001

Volltextzugriff (PDF)

Patterns of gastrointestinal hemorrhage in hemophilia

Gastroenterology (New York, N.Y. 1943), 1985-02, Vol.88 (2), p.515-522

1985

Volltextzugriff (PDF)

Parvovirus B19 infection in patients with hemophilia

Transfusion (Philadelphia, Pa.), 1996-03, Vol.36 (3), p.238-241

1996

Volltextzugriff (PDF)

Comparison of Bleeding Tendency, Factor XI Coagulant Activity, and Factor XI Antigen in 25 Factor XI-Deficient Kindreds

Blood, 1985-03, Vol.65 (3), p.719-724

1985

Volltextzugriff (PDF)

Antithrombin III during liver transplantation

Transplantation proceedings, 1989-06, Vol.21 (3), p.3543-3544

1989

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH

Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant

The use of thromboelastography for the peripartum management of a patient with platelet storage pool disorder

Pulmonary embolism in sickle cell disease: a case–control study

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study

Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C

Coronary atherosclerosis and cardiovascular mortality in hemophilia

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development

Inhibitor Recurrence Following Immune Tolerance Induction: A Multicenter Retrospective Cohort Study

Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study

Lack of desmopressin (DDAVP) response in men with hemophilia A following liver transplantation

Screening for von Willebrand disease in children: a case–control study

On the cutting edge: von Willebrand factor propeptide and thrombosis

RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD

The Prevalence of Reduced VWF Survival Phenotype (Type 1C VWD) in Type 1 Index Cases Recruited into the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB - VWD)

Novel VWF Sequence Variations Identified in Normal Controls and Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD)

Common VWF Haplotypes in Normal African-Americans and Caucasians Recruited into the ZPMCB-VWD and Their Impact on VWF Laboratory Testing

New-generation recombinant factor concentrates: bridge to gene therapy

Patterns of gastrointestinal hemorrhage in hemophilia

Parvovirus B19 infection in patients with hemophilia

Comparison of Bleeding Tendency, Factor XI Coagulant Activity, and Factor XI Antigen in 25 Factor XI-Deficient Kindreds

Antithrombin III during liver transplantation

Suchergebnisse filtern